Literature DB >> 10748870

Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.

Y C Hu1, K Y Lam, J C Tang, G Srivastava.   

Abstract

AIM: To investigate whether PTEN/MMAC1 mutations play a role in the carcinogenesis of oesophageal squamous cell carcinoma.
METHODS: A panel of 33 primary oesophageal squamous cell carcinoma tumour samples and 20 corresponding morphologically normal tissues was examined for mutations in all nine exons of the PTEN/MMAC1 gene by means of polymerase chain reaction single strand conformational polymorphism analysis (PCR-SSCP) and direct DNA sequencing methods.
RESULTS: Only one of 33 oesophageal squamous cell carcinomas showed an aberrant SSCP band. Further sequencing analysis of this sample revealed an 802 -29 T-->C substitution in intron 7. PTEN/MMAC1 mutations were not found in the mutational "hot spot" in exon 5, even after direct sequencing of six oesophageal squamous cell carcinoma samples and three normal tissues. However, a deletion of one nucleotide T at position 492 +8 in intron 5 was seen in all samples.
CONCLUSION: These results suggest that PTEN/MMAC1 mutations do not play a major role in the carcinogenesis of oesophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10748870      PMCID: PMC395722          DOI: 10.1136/mp.52.6.353

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  32 in total

1.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

2.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

Authors:  M Tamura; J Gu; K Matsumoto; S Aota; R Parsons; K M Yamada
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

3.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

4.  Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin.

Authors:  Y Kubo; Y Urano; Y Hida; S Arase
Journal:  J Dermatol Sci       Date:  1999-04       Impact factor: 4.563

5.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

7.  Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas.

Authors:  Y C Henderson; E Wang; G L Clayman
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

8.  Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.

Authors:  S Petersen; J Rudolf; U Bockmühl; K Gellert; G Wolf; M Dietel; I Petersen
Journal:  Oncogene       Date:  1998-07-30       Impact factor: 9.867

9.  Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.

Authors:  M A Davies; Y Lu; T Sano; X Fang; P Tang; R LaPushin; D Koul; R Bookstein; D Stokoe; W K Yung; G B Mills; P A Steck
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

10.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  10 in total

1.  PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma.

Authors:  Zhenguo Sun; Na Ji; Mingming Bi; Shuai Wang; Xiangyan Liu; Zhou Wang
Journal:  Tumour Biol       Date:  2015-02-28

2.  Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Authors:  Guiqin Hou; Zhaoming Lu; Mingyue Liu; Hongmin Liu; Lexun Xue
Journal:  Dig Dis Sci       Date:  2010-11-30       Impact factor: 3.199

3.  Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.

Authors:  Scott K Sherman; Jessica E Maxwell; Qining Qian; Andrew M Bellizzi; Terry A Braun; Mark D Iannettoni; Benjamin W Darbro; James R Howe
Journal:  Cancer Genet       Date:  2014-11-15

4.  Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma.

Authors:  Wen-Jing Ma; Guo-Dong Lv; Aerziguli Tuersun; Qing Liu; Hui Liu; Shu-Tao Zheng; Cong-Gai Huang; Jun-Guo Feng; Xing Wang; Ren-Yong Lin; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2010-11-20       Impact factor: 2.316

5.  Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.

Authors:  Jaw-Yuan Wang; Tsung-Jen Huang; Fang-Ming Chen; Ming-Chia Hsieh; Shiu-Ru Lin; Ming-Feng Hou; Jan-Sing Hsieh
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

6.  Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer.

Authors:  Pei Li; Wei-Min Mao; Zhi-Guo Zheng; Zi-Ming Dong; Zhi-Qiang Ling
Journal:  Dig Dis Sci       Date:  2013-09-25       Impact factor: 3.199

7.  Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.

Authors:  Michelle A T Hildebrandt; Hushan Yang; Mien-Chie Hung; Julie G Izzo; Maosheng Huang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544

8.  MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.

Authors:  Tingting Yu; Risheng Cao; Shuo Li; Mingen Fu; Lihua Ren; Weixu Chen; Hong Zhu; Qiang Zhan; Ruihua Shi
Journal:  BMC Cancer       Date:  2015-01-31       Impact factor: 4.430

9.  Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer.

Authors:  Enders K Ng; Vivian Y Shin; Candy P Leung; Vivian W Chan; Fian B Law; Man T Siu; Brian H Lang; Edmond S Ma; Ava Kwong
Journal:  Onco Targets Ther       Date:  2014-11-11       Impact factor: 4.147

10.  High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.

Authors:  Zhimin Zhang; Hualiang Xiao; Fei Xie; Hui Zhang; Chuan Chen; He Xiao; Zhenzhou Yang; Dong Wang; Zengpeng Li; Ge Wang
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.